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Escherichia coli associated with urinary tract infections and bacteremia has been intensively investigated, including recent
work focusing on the virulent, globally disseminated, multidrug-resistant lineage ST131. To contextualize ST131 within the
broader E. coli population associated with disease, we used genomics to analyze a systematic 11-yr hospital-based survey
of E. coli associated with bacteremia using isolates collected from across England by the British Society for Antimicrobial
Chemotherapy and from the Cambridge University Hospitals NHS Foundation Trust. Population dynamics analysis of
the most successful lineages identified the emergence of ST131 and ST69 and their establishment as two of the five most com-
mon lineages along with ST73, ST95, and ST12. The most frequently identified lineage was ST73. Compared to ST131, ST73
was susceptible to most antibiotics, indicating that multidrug resistance was not the dominant reason for prevalence of E. coli
lineages in this population. Temporal phylogenetic analysis of the emergence of ST69 and ST131 identified differences in the
dynamics of emergence and showed that expansion of ST131 in this population was not driven by sequential emergence of
increasingly resistant subclades. We showed that over time, the E. coli population was only transiently disturbed by the in-
troduction of new lineages before a new equilibriumwas rapidly achieved. Together, these findings suggest that the frequen-
cy of E. coli lineages in invasive disease is driven by negative frequency-dependent selection occurring outside of the hospital,
most probably in the commensal niche, and that drug resistance is not a primary determinant of success in this niche.
[Supplemental material is available for this article.]
Escherichia coli is a common commensal of the gastrointestinal
tract of humans and other vertebrates and can be isolated from
soil andwater. E. coli is also the leading cause of bloodstream infec-
tion in England, elsewhere in Europe and the United States (US)
(Elixhauser et al. 2011; de Kraker et al. 2013; Gerver et al. 2015).
Annual rates increased in England by 80% between 2003 and
2011 (from 16,542 to 29,777), which led to the introduction of
mandatory surveillance from 2011. This documented a 10% in-
crease between 2012/2013 and 2014/2015 from 32,309 to
35,676 cases (Gerver et al. 2015). The most common underlying
causes for bloodstream infection in a national collection of
the British Society for Antimicrobial Chemotherapy (BSAC)
Bacteraemia Resistance Surveillance Programme during 2001–
2010 related to urinary tract infection (UTI) and gastrointestinal
and hepatobiliary infections (Day et al. 2016).
Previous genetic studies of E. coli lineages associated with UTI
and/or bacteremia in England and the US have reported that the
most prevalent multilocus sequence types (MLSTs) are sequence
types (STs) ST73, ST131, ST95, and ST69 (Gibreel et al. 2012;
Adams-Sapper et al. 2013; Alhashash et al. 2013; Banerjee et al.
2013; Horner et al. 2014). ST131 has received particular attention,
following its apparent emergence in the 2000s, due to its rapid
global dissemination and frequentmultidrug-resistant (MDR) phe-
notype (Nicolas-Chanoine et al. 2014). This has led to ST131 being
well characterized by publications that propose biological explana-
tions for its emergence and spread (Price et al. 2013; Petty et al.
2014; Salipante et al. 2015; Ben Zakour et al. 2016; Stoesser et al.
2016). Other common STs are less well characterized despite their
associationwith disease, in part because they are less often defined
as MDR and because ST131 is an important player in the broader
globalproblemof increasingantibiotic resistance inGram-negative
bacteria, with clinical isolates that are resistant to aminoglycosides,
fluoroquinolones, extended-spectrum beta-lactamases, carbape-
nems, and colistin beginning to emerge (Chen et al. 2014; Zhang
et al. 2014; Liu et al. 2016; Skov and Monnet 2016).
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Many of the published whole-ge-
nome sequencing (WGS) studies on E.
coli have largely concentrated on ST131,
with fewer focused on other extraintesti-
nal pathogenic E. coli (ExPEC). Studies
have characterized ST131 in detail and
highlighted genetic events leading to
the success of this lineage. Two studies
investigating the origin of enteropatho-
genic E. coli (EPEC) and atypical entero-
pathogenic E. coli (aEPEC) and the
association of genetic factors with clini-
cal disease severity illustrated the power
of WGS by showing that aEPEC and
EPEC emerged several times in different
lineages (Hazen et al. 2016; Ingle et al.
2016), and a further study analyzed a
global collection of 362 enterotoxigenic
E. coli (ETEC) (von Mentzer et al. 2014).
Smaller studies of local epidemics have
concentrated on other pathotypes and
single STs.
Here, we used WGS to analyze the
genetic diversity of a large collection of
E. coli isolates associated with blood-
stream infection over more than a dec-
ade, using nested systematic surveys of
England and the Cambridge area. These
were not selected based on ST or other
bacterial characteristics. We investigated
trends in population structure andmech-
anisms of antibiotic resistance and cap-
tured the introduction of ST131 and
ST69, which enabled us to study the dy-
namics of emergence and its effect on
the wider E. coli population.
Results
Study design and bacterial isolates
We conducted a retrospective study in
which we analyzed WGS data for 1509
E. coli isolates drawn from national
BSAC (n = 1094) and local (n = 415) col-
lections. The BSAC collection consisted
of isolates submitted to a Bacteraemia Resistance Surveillance
Programme (www.bsacsurv.org) between 2001–2011 by 11 hospi-
tals across England. From each hospital, the first 10 isolates (when
available) for each year were included into the study. The local col-
lection was sourced from the diagnostic laboratory at the
Cambridge University Hospitals NHS Foundation Trust (CUH),
Cambridge. By using the laboratory database, we selected every
third isolate associated with bacteremia that had been stored in
the −80°C freezer archive between 2006 and 2012.
Phylogeny and pan-genome
The 1509 E. coli isolates were resolved into 228 STs. The most fre-
quent STs were ST73 (17.3%), ST131 (14.4%), ST95 (10.6%),
ST69 (5.5%), and ST12 (4.6%), which accounted for more than
half of the collection. The distribution of STs between the BSAC
and CUH collections was comparable. Details of all STs are pro-
vided in Supplemental Table S1 (Supplemental Figures and
Tables S1). The population structure of the collection based on
core genome single-nucleotide polymorphisms (SNPs) was defined
using Bayesian analysis of population structure (BAPS), which pro-
vides an independent method of assessing the population struc-
ture based on the data in the collection, not based on previous
definitions. This correlated well with ST (Fig. 1), and we therefore
used STs to allow for direct comparisons between our data and pre-
vious studies. However, there were inconsistencies with phy-
logroups, which have been linked to the source of isolation and
virulence (Picard et al. 1999) and have been previously used to
describe the E. coli population structure (Lecointre et al. 1998).
Most isolates (n = 1018, 67%) were assigned to phylogroup B2.
The remainder were distributed among phylogroups F (n = 151,
10%), A (n = 130, 9%), D (139, 9%), B1 (n = 69, 5%), and E (n = 2,
Figure 1. Maximum-likelihood core genome phylogeny of E. coli associated with bacteremia in
England. The columns on the right show, from left to right, phylogroup, STs containing more than 10
isolates, and hierBAPS clusters. Phylogroups are also presented by background shading and STs labeled
on the right. Black represents ST designation not shown due to these having fewer than 10 isolates. The
root has been placed according to previous understanding of Enterobacteriaceae phylogeny.
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<1%) (Fig. 1). Four of the five most common STs resided in phy-
logroup B2 (ST73, ST131, ST95, and ST12), while ST69 belonged
to phylogroup D. A comparison of ST, BAPS clusters, phylogroup,
and a maximum likelihood (ML) tree based on core genome SNPs
is shown in Figure 1. The phylogeny showed five large clades,
which generally correspond to phylogroups. However, compari-
son between phylogroup and core genome-based phylogeny
showed that phylogroups F and D were mixed rather than mono-
phyletic groups (Fig. 1). This is consistent with the PCR data from
Clermont et al. (2013), as well as the presence of an A genotype
within the B1 group (Clermont et al. 2013). TheML tree was dom-
inated by phylogroup B2, which showed large clonal expansions.
These were mostly absent from groups A and B1, which were in
turn dominated by isolates on long branches.
Analysis of the pan-genome demonstrated an open pan-ge-
nome containing 69,274 genes and no sign of reaching a plateau
(Supplemental Fig. S1). By use of a strict definition of core genome,
only 885 genes were present in all 1509 isolates, although this rose
to 1744 genes using a cut-off of presence in 99% of isolates. The
vast majority of genes (62,753 of 69,274, 91%) were present in
<15% of the isolates.
The population structure of E. coli associated with bacteremia
Two STs appeared in the collection for the first time during the
timeframe of the study, with ST69 first detected in 2002 and
ST131 in 2003. The proportion of STs in each year of the collection
is shown in Figure 2. Within a short period after the emergence
and spread of ST69 and ST131, the population established a new
equilibrium, whereby the proportion of the major STs remain rel-
atively unchanged. The proportion of ST73, ST95, and ST12 before
and after the emergence of ST131 was on average 24% versus 17%,
8% versus 11%, and 7% versus 4%, respectively. The proportion
of the remaining STs fell from 59% before the emergence of
ST131 to 42% after but was stable from then until the end of the
sampling period.
Genetic characterization of ST131
Three major clades have been identified for ST131 (Price et al.
2013; Petty et al. 2014): Clade A corresponds to serotype O16:
H5, clade B is serotype O25:H4 and is negative for the fimH30 al-
lele, and clade C (H30) is serotype O25:H4 and is positive for
fimH30 and subdivided by the acquisition of fluoroquinolone re-
sistance in clade C1 (H30-R in Price et al. 2013). This has been fur-
ther divided into clade C2 (H30-Rx in Price et al. 2013), described
previously as having acquired blaCTX-M-15 encoding extended
spectrum beta-lactamase (ESBL), followed by expansion of this
clade (Price et al. 2013; Olesen et al. 2014). Our 218 ST131 isolates
were assigned to these lineages using previously described lineage-
defining variation. This demonstrated that 197 (90%) were sero-
type O25:H4, and 18 (9%) isolates at the base of the lineage were
serotype O16:H5 and fimH41. For two isolates, the serotype could
not be explicitly defined in silico, and one was defined as O18ac:
H4. One O25:H4 isolate was within the O16:H5 positive clade
A. The C1 clade was defined based on a comparative phylogenetic
analysis with the Price et al. (2013) isolates (Supplemental Fig. S2)
and in silico PCR to detect H30-Rx (C2)–specific SNPs. Of the 161
ST131 isolates in lineage C, 129 belonged to the C2 clade (Fig. 3).
The assignment of isolates to clades was confirmed by investigat-
ing six previously reported clade specific SNPs for B, C, C1, and
C2 (Ben Zakour et al. 2016). This confirmed our assignment of
isolates to clades and revealed that the three fimH27 isolates in
the B clade most likely belong to the B0 clade defined by Ben
Zakour et al. (2016).
We then mapped blaCTX-M-15 and fluoroquinolone resistance
across the ST131 collection. blaCTX-M-15 was present in bothC1 and
C2 clades but was not detected in clades A or B (Fig. 3). A parsimo-
ny reconstruction of the presence of blaCTX-M-15 within a EC958
reference genome-based ML phylogeny using both acctran and
deltran methods indicated at least 28 introductions and/or losses
of the blaCTX-M-15 gene in this data set. This indicates that blaCTX-
M-15 has been acquired and lost repeatedly in the C1 and C2 clades
(Supplemental Fig. S3). The majority of the fimH30-positive C iso-
lates were ciprofloxacin (fluoroquinolone) resistant, with a small
number of exceptions. A cluster of eight fluoroquinolone-suscepti-
ble isolates resided close to the root of the C clade, together with
two sporadic isolates in theC1/2 clade. Altogether, 75 of ST131 iso-
lates were blaCTX-M-15 positive. The C1 clade contained only 23 iso-
lates, but of these, two were blaCTX-M-15 positive and another four
had acquired blaCTX-M-27. Of the 129 clade C2 isolates, 73 were
blaCTX-M-15 positive. Isolates in lineage A and Bweremostly suscep-
tible to ciprofloxacin, the exceptions being one isolate in clade A
that was resistant to ciprofloxacin and two clade A isolates with in-
termediate resistance. The resistant isolate had the gyrA mutation
associated with fluoroquinolone resistance (gyrA1AB) (Johnson
et al. 2013).
ST131 espC island
We analyzed the presence of 3511 virulence genes in the whole
collection and observed that just one gene was almost specific to
the ST131. This was present in ST131 and the closest lineages in
the B2 phylogroup. This was more common in ST131 (N = 216,
99.08%) compared with other STs (P-value <2.2 × 10−16). The
gene was annotated as espC (a member of the serine protease auto-
transporters of Enterobacteriaceae, [SPATE] family). The gene is con-
tained in a genetic island reported previously as ROD3 in ST131
strain EC958 (Totsika et al. 2011), but is not identical to the first
description of an espC pathogenicity island that was originally re-
ported in EPEC (Stein et al. 1996; Mellies et al. 2001; Schmidt and
Hensel 2004). The sequence identity/similarity of the EPEC espC
and EC958 espC was 68% for DNA and 69%/73% for protein.
The ST131 espC island has genes coding for fimD, focC ( fimC),
tsh, cfaD (regA), and espC, alongwith two poorly characterized pro-
teins, one with similarity to fimbrial adhesins and one to DNA
Figure 2. Proportions of STs during the 11-yr sampling framework. The
percentage of each ST has been plotted by year ordered by the frequency
at the start of the study (most common at the bottom). The emergence of
ST131 and ST69 can be observed in 2003 and 2002, respectively.
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binding proteins. The island is bordered by yjdJ genes. The locus
where the island is inserted is conserved at the yjdIJKO gene region,
between the dcuS and lysU genes in E. coli reference strain K-12
MG1655 (NC_000913.2). Analysis of mapping coverage to the ref-
erence EC958 showed that the island was present in all ST131 iso-
lates (N = 218), closely related clades to ST131 in the B2 phylogeny
(N = 45), and four isolates in phylogroup D and six in phylogroups
B1/A. A region of the island is missing from 11% of the ST131 iso-
lates, 19 of which belong to the clade A and were missing a com-
mon region. The same region was missing in the clades close to
ST131 in the phylogeny (Supplemental
Fig. S4). The espC allele present outside
of the ST131 clades B andCwas often dif-
ferent than the espC in the rest of ST131
(Supplemental Fig. S5).
ST73 and ST131 have different strategies
to achieve prevalence
ST73 and ST131 represented the predom-
inant STs in the collection but are known
to have contrasting antibiotic-resistance
profiles. Consistent with this, our ST131
isolates were predominantly MDR, and
ST73 was largely susceptible (Fig. 4;
Supplemental Fig. S6). This was reflected
by the presence of numerous antibiotic-
resistance genes in ST131 compared
with ST73, which was accounted for at
least in part by different plasmid profiles.
ST131was themain lineage in the collec-
tion to carry an incFIA plasmid(s) (Fig. 4;
Supplemental Fig. S6). This contained
aac6′-lb-cr, blaCTX-M-15, and blaOXA1 and
indicates that this plasmid is mostly
responsible for the multidrug-resistant
ST131 phenotype (Supplemental Fig.
S6). A more widely disseminated plasmid
in ST131 was also present and carried
incFIB often in addition to incFIA. This
plasmid encodes blaTEM-1, dfrA, mphA,
sul1, and tetA. Due to the limitations of
Illumina short-read technology, it is not
possible to further delineate the structure
of the genetic element encoding these
genes, and therefore, the presence of
genes in specific plasmids is determined
by association alone andhas a level of un-
certainty. The difference in susceptibility
profiles of ST73 andST131,which remain
at stable proportions of the population
throughout the study after the introduc-
tion of ST131, suggests that resistance
may not be the primary determinant of
successful establishment and mainte-
nance in the reservoir niche.
Comparing the phylogeny of the
two lineages showed that ST131 was
mainly dominated by clade C isolates,
which were very closely related, but the
ST73 tree has several more divergent
clades. The average pairwise SNP distance
between all the ST131 isolates was 156 SNPs (median = 74 SNPs)
(Fig. 3). In contrast, the ST73 phylogeny comprised at least eight
clades with isolates that were much less closely related (average
pairwise SNP distance in ST73 is 335 SNPs, median = 332 SNPs)
(Fig. 5). This is underlined by the observation that ST73 isolates
were assigned to nine serotypes in silico, and the different sero-
types were in phylogenetically separate lineages. It seems likely
that a change in serotype has occurred at least seven times in
ST73 (Fig. 5). In contrast, within ST131 only three serotypes were
identified. O16:H5was present in clade A, andO25:H4was present
Figure 3. ST131 maximum-likelihood phylogenetic tree based on SNPs called against the reference
EC958. Columns to the right of the tree show the in silico predicted serotype (O16-H5 or O25-H4); phe-
notypic resistance to ciprofloxacin (CIP res.); SNP-based definition of fimH, gyrA, and parC genotypes;
and the presence of blaCTX-M and the type. NA:H4 in the serotype indicates that wewere unable to assign
a definite O type for the isolate. It has not been counted as a new serotype. Clades assigned based on the
markers and clade-specific SNPs are shown on the right. The only isolate with missing data (black) is the
reference strain EC958. The tree is mid-point rooted.
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in the rest of the phylogeny represented by clades B and C. One
isolate in the C2 clade was O18ac:H4. A comparison of the
presence of virulence genes in ST73 and ST131 revealed differences
in the presence of the UPEC/ExPEC virulence genes between
the two (Supplemental Fig. S5), suggesting that, again, there is
not a single configuration that is best for success in this niche rep-
resented by MDR ST131, but, rather, also susceptible, but fit and
virulent, STs can become prevalent. For example, most ST131
isolates lacked gene clusters hlyABCD (hemolysin) and iroBCDN
(salmochelin) but carried genes for aerobactin (iucABCD, iutA), he-
min uptake (chuASTUWXY), and yersiniabactin ( fyuA, irp1, irp2,
ybtAEPQSTUX) (Supplemental Fig. S7). It seems that ST131 can
use only aerobactin, yersiniobactin, and the chuASTUWXY for
iron acquisition, but for example, ST73 has the potential to use
all these and others.
An interesting similarity between the twomost prevalent lin-
eages ST131 and ST73 is that both are positive for sat (ST131 89%
and ST73 87%), a gene encoding a secreted autotransporter toxin
that is toxic for kidney and bladder cell lines (Guyer et al. 2000)
and is less widely present in rest of the population (27%; P-values
<2.2 × 10−16). Another similarity is the absence of aec genes in ST73
and ST131 (except aec7, which is present in ST73), which encode
genes associatedwith type 6 secretion, al-
though they were widely present in the
rest of the phylogeny (Supplemental
Fig. S5).
Two strategies for emergence—ST131
and ST69
Two independent lineages (ST69 and
ST131) became established in our study
population during the study period.
To investigate the structure and history
of this emergence,weconstructed tempo-
rally resolved phylogenies using Bayesian
evolutionary analysis by sampling trees
(BEAST). Based on the BEAST analysis,
the MRCA (most recent common ances-
tor) for ST69 was dated to 1956 (95%
highest posterior density [HPD] interval,
1935–1971). This separated the major
clade in the ST69 tree that subsequently
divided into two large lineages in 1977
(95% HPD interval, 1965–1986) (Supple-
mental Fig. S8). By using the Bayesian
skyline model, we could estimate the ef-
fective population size in the past. The
analysis showed three increases in the
population size. The first increase begin-
ning in the late 1970s and the second in
the 1990swere smaller than the last rapid
increase that occurred relatively close to
the year 2000 (Supplemental Fig. S9). If
the confidence interval is taken into ac-
count, we hypothesize that we observed
the last increase in population size during
this study.
The BEAST analysis estimated that
the MRCA of the clades with the two dif-
ferent serotypes in ST131 was around
1874 (95% HPD interval, 1697–1951)
(Fig. 6; Supplemental Fig. S10). The C clade diverged from the
rest of the phylogeny around 1960 (95% HPD interval, 1899–
1985), and the fluoroquinolone-resistant C1 clade is estimated to
have diverged from the rest of the ST131 lineages around 1982
(95% HPD interval, 1948–1995). We repeated this analysis with
least-squares dating (LSD), which gave a date for the MRCA of
the complete ST131 collection of 1828 (confidence interval
1672–1891), 1934 (1871–1960) for divergence of clade C from A
and B clades, 1979 (1953–1991) for divergence of the fluoroquin-
olone-resistant clade from the rest, and 1986 (1965–1993) for the
divergence of C2 clade from C1. The majority of the ST131 nodes,
including the fluoroquinolone-susceptible lineages in the tree had
a divergence time of ≤30 yr. This is indicative of the fact that the
whole ST131 lineage, rather than just a single clade within it,
has increased in prevalence after its observed emergence in
England in the 2000s. This is also apparent from an analysis of iso-
lation dates against the phylogeny of ST131 in our collection
(Supplemental Fig. S11). It can be seen that nearly all of the major
clades of the tree contained isolates from every year, indicating
that the whole population was present in each year throughout
the 11 yr in this study, not just the clade C2. The skyline plot
showed a sharp increase in the population size around the year
Figure 4. Multidrug-resistance plasmids present in ST131. Phylogeny of the whole collection with col-
umns to the right representing phylogroup, the five most frequent STs, phenotypic antibiotic-resistance
data linked to the plasmid (ceftazidime, ciprofloxacin, cefotaxime, cefuroxime- and gentamicin), the
presence of incFIA and incFIB, and antibiotic-resistance genes carried by the plasmid (aac(6′)-Ib,
blaCTX-M, blaOXA, dfrA, mphA, sul1, and tetA). (Black) Missing; (color) present. The phylogenetic tree is
the same as in Figure 1.
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2000 (Supplemental Fig. S9). This most likely correlates with the
emergence of the ST131 lineage that we observed in our data set.
Distribution of virulence factors
We analyzed the repertoire of virulence factors, focusing on genes
present or absent in the most prevalent sequence types in our col-
lection, ST73 and ST131. ST131 is known to cause UTIs, yet this
clade has only a partial pap (P fimbriae or pyelonephritis associated
pilus) gene operon (Clark et al. 2012): 82% of ST131 had only
papABIX or fewer genes from the operon and not, for example,
the tip adhesin papG. In more detail, 90% of ST131 isolates had
papA, but only 17% had the tip adhesin papG (Supplemental Fig.
S7). Most of the other clades in the B2 phylogroup contained the
intact operon, which was also present in other phylogroups. In ad-
dition, the most closely related clades to ST131 were also missing
most of this operon. Genes encoding enterotoxins set1AB, auto-
transporter pic, F1C fimbrial genes focAGH, and the autotrans-
porter upaH (Supplemental Fig. S5) were found in ST73 but were
rare in other STs.
Mapping against the reference strain EC958 also enabled us to
analyze the presence of the reported ST131 genomic island ROD3
(Totsika et al. 2011) and the type 6 secretion system (T6SS) across
the whole invasive E. coli population in England (Supplemental
Fig. S4). T6SS was specific to the B2 phylogroup. The T6SS is
used as an anti-competition mechanism to enhance survival in a
competitive niche such as the gut (Chatzidaki-Livanis et al.
2016; Sana et al. 2016). This may be one explanation for the prev-
alence of the B2 phylogroup in our collection.
Antibiotic resistance
Phenotypic antibiotic resistance to ciprofloxacin increased from
10.5% to 28.8% (probably due to the emergence of ST131) and
peaked in 2006, but it remained under 20% from 2008–2012. It
is striking that there was no consistent change in the phenotypic
antibiotic resistance of the two most prevalent sequence types,
ST73 and ST131, except for ampicillin resistance in ST73 (Fig. 7).
Furthermore, there was no clear increase in antibiotic resistance
over time for the whole collection. ST131 was more resistant to
most antimicrobials than ST73 (and often the rest of the collec-
tion) and contained the most antibiotic-resistance genes (Fig. 4).
However, the equally successful ST73 was one of the least resistant
lineages to most antimicrobials. Phenotypic antibiotic susceptibil-
ity results are summarized in Table 1.
Discussion
We analyzedWGS data for 1509 E. coli blood isolates taken from a
systematic sentinel-based surveillance program across England, as
well as unbiased sampling from a university hospital, isolated in
2001–2012. This 11-yr period enabled us to analyze the temporal
trends in the population structure and changes in the antibiotic re-
sistance of invasive E. coli, as well as characterize in detail themost
prevalent sequence types causing bacteremia. The most predomi-
nant STs were ST73, ST131, ST95, ST69, and ST12. These belong
to E. coli phylogroups B2 and D, which have been previously asso-
ciated with virulent and pathogenic UPEC and ExPEC strains
(Picard et al. 1999; Johnson and Stell 2000; Johnson et al. 2001).
The fact that some of the genotypes from the (in silico) PCR did
not present monophyletic clades made it difficult to assign all iso-
lates to phylogroups without the use of a phylogenetic tree. The
pattern of prevalence of STs is consistent with previous studies of
isolates associated with urinary sepsis or bloodstream infection;
for example, during a similar time period in Ireland the most fre-
quent STs were ST131, ST73 and ST69 (Miajlovic et al. 2016) and
the E. coli from the BSAC Bacteraemia Resistance Surveillance
Programme have the same most common profiles (CC73, CC131
and CC95) as this combined collection from BSAC and CUH
(Day et al. 2016). This also shows that the collections from BSAC
and CUH are similar when STs are considered. Information from
hierBAPS clustering showed that BAPS clusters were more often
monophyletic than STs since single and double locus variants of-
ten disturbed the uniformity of ST clades. The presence of phy-
logroup F isolates within group D, already reported in the
original article presenting the method (Clermont et al. 2013),
made the use of the current PCR-based method for assigning iso-
lates to phylogroups problematic for some clades.
The study period captured the emergence of ST69 and ST131
into our study population, but the introduction of these lineages
only disturbed the population structure transiently, after which
it quickly reached a new equilibrium, with the new lineages subse-
quently maintaining a stable proportion of the population.
Despite its apparent success, the globally disseminated MDR line-
age ST131 failed to become dominant in the whole population.
The most common lineage prior to the emergence of ST131,
ST73, only reached a proportion of >20% of the whole population
in a single year. This suggests that the driver for the overall struc-
ture of the population and proportions of successful clones may
Figure 5. ST73 maximum-likelihood phylogenetic tree based on SNPs
called against the reference CFT073. The in silico predicted serotype is
shown to the right of the tree. For serotype NA:H1 the O type could not
be assigned. This is not counted as a new serotype. The clades are labeled
on the right. The tree is mid-point rooted.
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be a form of negative frequency-dependent selection. New STs
have an advantage when rare, but this is lost when they become
more common. One hypothesis to explain this is that the E. coli
causing bloodstream infections do not form a discrete population
but represent a spill-over of E. coli that occupies a commensal niche
in thewider humanpopulation. This is supported by evidence that
both drug-resistant (ST131) and drug-susceptible (ST73) lineages
are equally successful in being maintained in this reservoir and
that drug resistance as a whole in the population is not increasing,
demonstrating that antibiotic resistance is not a primary driver of
success or prevalence in this niche. In the case of ST131, this is sup-
ported by the findings of Ben Zakour et al. (2016), who reported
that virulence determinants were acquired before the emergence
of the fluoroquinolone-resistant C clade (Ben Zakour et al. 2016).
According to this hypothesis, the primary forces shaping the
population are not those within the hospital environment but
are due to competition within the gut commensal niche in the
broader human population, where antibiotic use is more sporadic
than in the hospital population. This is a strong contrast with the
population structure of true nosocomial pathogens such as meth-
icillin-resistant Staphylococcus aureus (MRSA), where specific drug-
resistant clones sequentially dominate the population within a
niche where antibiotic exposure is common and drug resistance
is a strong selective advantage.
ST73 in our collection was susceptible to the antibiotics test-
ed, but a recent report from the United Kingdom found several
MDR ST73 isolates associated with an MDR plasmid (Alhashash
et al. 2016). Further studies are needed to define whether this
MDR phenotype will become more disseminated in ST73 over
time.
Although previously reported to be present in the United
Kingdom and Ireland from 2001 (Day et al. 2016), we observed
the appearance of ST69 and ST131 within our sampling frame-
work. We used BEAST to analyze their emergence and found that
the events leading to their spread seem quite different. A
Bayesian skyline analysis of ST69 showed several sequential minor
increases in population size, which started in the late 1970s with
the last and most rapid one coinciding with the beginning of
this study. Themost recent commonancestor of ST69 could be dat-
ed to ∼60 yr ago. A similar analysis of the ST131 lineage identified
that the split between the O25:H4 and O16:H5 lineages occurred
∼143 yr ago. The phylogeny and the Bayesian skyline analysis sup-
port the observation that there was a single rapid expansion of this
clade in the last few years, starting around 1995. However, rather
than being due to a single sublineage, this expansion seems to
have happened in the entire O25:H4 clade and possibly the whole
ST. According to our analysis, the fimH30 carrying cladeC diverged
from clade B around 1960, the fluoroquinolone-resistant clade C1
(H30-R) diverged from clade C around 1982, and the clade C2
(H30-Rx) diverged from the rest of clade C around 1990. These
dates are somewhat different from the recently published analyses
of Stoesser et al. (2016) and Ben Zakour et al. (2016). The emer-
gence of the fluoroquinolone-resistant subset of the C clade in
the 1980s found here is consistent with two previous publications.
Similarly, the divergence of the C2 clade from the C1 in 1990 re-
ported here is similar to the year of 1987 reported by Ben Zakour
et al. (2016) and Stoesser et al. (2016). This indicates a strong tem-
poral signal in the sequences for these genetic events. The differ-
ence in other dates are most likely due to weaker temporal
signals in the data for these events, for example, the divergence
of the C clade from B clade is dated close to the year 1960 by
Ben Zakour et al. (2016) and in this study but to 1985 by
Stoesser et al. (2016). The fact that all of the ST131 clades were pre-
sent during the whole study period indicates that the entire ST131
lineage is successful andnot just cladeCor the fluoroquinolone-re-
sistant and ESBL-expressing clades C1 and C2.
Figure 6. Temporal analysis on ST131 using BEAST. Figure shows the serotype, resistance to ciprofloxacin (CIP res.), assignment to clade C2 (H30-Rx),
and the gene alleles of fimH, gyrA, and parC. (∗) MRCA; (∗∗) emergence of clade C; (∗∗∗) emergence of CIP-resistant clade C1.
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For ST131, the presence of blaCTX-M-15 was initially reported to
be exclusive to the H30-Rx (C2) clade (Price et al. 2013). In our col-
lection, blaCTX-M-15 was found in both the C1 and C2 clades. We
also identified that blaCTX-M-15 was acquired and/or lost several
times in the ST131 population studied here. Stoesser et al. (2016)
had previously hypothesized that this could occur based on the
diverse contexts in which the gene is found. It is also noteworthy
that our unbiased sample of E. coli causing BSI was dominated by
Figure 7. Comparison of antibiotic resistance of ST131, ST73, and the whole collection. Phenotypic antibiotic-resistance data are represented by the
percentage of nonsusceptible (resistant + intermediate) isolates per year. Each subfigure represents one antibiotic class. Carbapenems (imipemen, mero-
penem, and ertapenem) and tigecycline are not shown due to the lack of resistance against these classes in this collection. (AMK) Amikacin; (GEN) gen-
tamicin; (TOB) tobramycin; (TMP) trimethoprim; (CEF) cefalotin; (FOX) cefoxitin; (CXM) cefuroxime; (FEP) cefepime; (CTX) cefotaxime; (CAZ)
ceftazidime; (AMX) amoxicillin; (AMP) ampicillin; (CIP) ciprofloxacin; (ATM) aztreonam; (AMC) amoxicillin-clavulanic acid; (TZP) piperacillin-tazobactam.
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C2 isolates, with >80% of clade C isolates and ∼60% of all the iso-
lates belonging to clade C2. This is in contrast to the previous re-
ports of the ST131 population structure where the C1 and C2
have been more equally distributed (Price et al. 2013; Petty et al.
2014; Ben Zakour et al. 2016; Stoesser et al. 2016).
The pan-genome of our collection of invasive E. coli included
almost 70,000 genes. The core was very small, and most of the
genes in the pan-genome were present in a small subset of strains,
reflecting the massive diversity of E. coli. Previous reports on the
size of the E. coli pan-genome have been markedly smaller, but
also, the data sets that the analyses were performed on have
been smaller. With an open pan-genome, this will have an effect
on the pan-genome size. Rasko et al. (2008) reported a pan-ge-
nome of over 13,000 genes and a core of 2200 genes from an anal-
ysis of a diverse set of 17 genomes from different E. coli pathovars.
Chen et al. (2006) analyzed the pan-genome and core genome of
seven UPEC isolates and reported a core genome of 2865 genes.
Both of these estimates of the core are considerably larger than
ours. This may be due to the high similarity cut-off in our analysis,
which will make the core genome appear smaller and the pan-ge-
nome larger. However, evenwith a cut-off of 90% the pan-genome
is 46,022 genes in this data set and the core genome 1170 genes.
Recently, a core of 1080 gene clusters was reported in a study inves-
tigating 70 EPEC isolates using large-scale BLAST score ratio analy-
sis (Hazen et al. 2016). This is closer to our number of 885 core
genes even though the pan-genome in the analysis by Hazen
et al. (2016) was only 12,964 gene clusters. This is likely due to
the different methods that were used in the analyses.
The proportion of antibiotic-resistant isolates in the data set
did not increase substantially during the 11 yr that were included
in this study. The resistance patterns fluctuated over time, which
was probably due to the relatively small sample size per location
per each year. Despite the fact that we did not observe a clear in-
crease in the proportion of resistance, there have beenmany recent
reports suggesting an increase in the proportion of resistant iso-
lates (ESPAUR 2015; Ironmonger et al. 2015). This may be due to
differences at the regional level, while this study was performed
at a nationwide level, and therefore, smaller increases at a local lev-
el might not have been apparent.
The analysis of virulence factors in this diverse population en-
abled us to compare themost successful lineages to each other and
to the rest of the population. We identified a number of virulence
factors that were differentially present between lineages. One
gene, the SPATE espC, was specific to ST131 and closely related lin-
eages. This is situated in a pathogenicity island that is restricted al-
most exclusively to ST131 and its closest clades. This island was
first reported by Totsika et al. (2011) as a region of difference 3
(ROD3), and has previously been reported to be present through-
out ST131 by Petty et al. (2014) but not to be conserved in clade
A (Totsika et al. 2011; Petty et al. 2014). Since the ST131 espC island
does not have an integrase or othermobility-related genes, it is not
clear if it is a self-mobile element. Its sporadic acquisition in differ-
ent branches of the tree could reflect acquisition by mechanisms
other than self-mobility (such as homologous recombination in
flanking sequences) or could potentially represent lineage-specific
deletion. In EPECs, espChas been shown to play a role in cell death
Table 1. Proportion of antibiotic nonsusceptible isolates in each year
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Aminoglycosides
Gentamicin 10.5 5.7 2.8 4.6 7.5 11.7 12.7 12.1 4.1 7.2 9.4 5.0
Amikacin 0.0 3.8 7.0 5.6 3.0 1.4 3.0
Tobramycin 0.0 15.4 10.5 9.7 7.6 12.7 8.9
Antifolates
Trimethoprim 50.0 42.3 31.6 34.7 28.8 33.8 36.6
Beta-lactams
Extended spectrum penicillins
Amoxicillin 55.3 58.5 63.0 46.8 59.8 66.4 62.2 71.0 65.0 63.2 53.0
Ampicillin 50.0 59.6 50.9 56.9 54.5 63.4 65.3
Carbapenems
Imipenem 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0
Ertapenem 0.0 0.0 0.0 1.4 0.0 0.0 0.0
Meropenem 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Monobactams
Aztreonam 0.0 0.0 8.8 9.7 3.0 9.9 8.9
First- and second-generation cephalosporins
Cefalotin 75.0 63.5 49.1 47.2 50.0 53.5 59.4
Cefuroxime 13.2 10.4 8.3 14.7 15.0 20.7 15.3 22.3 22.7 14.4 13.5 13.9
Cefoxitin 25.0 5.8 5.3 8.3 9.1 5.6 5.9
Cefuroxime axetil 25.0 11.5 17.5 20.8 12.1 14.1 13.9
Third- and fourth-generation cephalosporins
Ceftazidime 0.0 4.7 2.8 3.7 10.3 12.6 8.0 10.8 8.7 2.6 9.9 9.9
Cefotaxime 3.8 2.8 6.4 9.3 13.5 9.3 13.4 7.0 3.9 11.1 8.9
Cefepime 0.0 7.7 7.0 1.4 3.0 7.0 5.0
Quinolones
Ciprofloxacin 10.5 8.5 12.0 21.1 16.8 28.8 26.7 19.7 15.7 17.0 19.9 17.8
Tetracyclines
Tigecycline 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0
Combinations
AmoxiClava 19.7 27.4 27.8 21.1 29.0 42.3 30.0 33.1 36.6 28.1 26.9 27.7
PipTazb 6.6 9.4 9.3 27.5 4.7 19.8 4.7 12.1 9.4 6.5 2.3 7.1
aAmoxicilline clavulanic acid.
bPiperacillin tazobactam.
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by causing apoptosis and necrosis (Serapio-Palacios and Navarro-
Garcia 2016), and the ST131 espC islandhas recently been reported
to harbor a gene encoding the regulatory protein RegA (annotated
as cfaD by Prokka in our analysis) that is present in Citrobacter
rodentium and Escherichia clades III, IV, and V (Tan et al. 2015).
Incorporation of this island may be one reason for the success of
ST131. There were several genes present almost exclusively in
ST73 that could in part contribute to its success. These genes
were focAGH (encoding F1C fimbriae genes), pic (encoding another
SPATE gene), set1AB (encoding Shigella enterotoxin 1), and upaH,
which is an autotransporter that induces biofilm formation and
bladder colonization (Allsopp et al. 2010, 2012). The secreted auto-
transporter toxin encoded by sat (another SPATE gene) was present
in both ST131 and ST73 and could be contributing to the success
of both lineages.
One limitation of this study is that although the collection
was drawn from 11 centers over 11 yr, it only comprised the first
10 isolates per site each year except in the case of CUH. It could
therefore potentially include isolates from temporally limited local
epidemics, which could skew the results and interpretation. In
addition, the limitation of short-read sequencing is evident
when analyzing plasmids. The dynamic nature of plasmids, in
combination with short reads generated by the Illumina HiSeq,
means that many differences in plasmid structure are unlikely to
be captured by our analyses. We are also unable to assemble com-
plete plasmid sequences, and so the presence of genes in plasmids
with given inc-types is based on association alone. More detailed
analysis would require the use of long-read technologies. Deter-
mining the presence of genes by association alone adds a degree
of uncertainty to the results due to untypeable plasmids and the
mobile nature of the genetic elements that can be present in the
chromosome.
In summary, we have analyzed the population structure of E.
coli associated with bloodstream infection over an 11-yr period in
England. During this time, we observed the emergence of ST131
and ST69, but this introduction did not disturb the population
structure for long, and a new equilibrium was quickly established.
The globally disseminated MDR lineage ST131 was not the most
frequently identified lineage in this collection; this was ST73,
which is generally susceptible to most antibiotics. This indicates
that antibiotic resistance is not a primary driver of success in the
niche occupied by these E. coli. The relatively static structure of
the population suggests that it is instead driven by negative fre-
quency-dependent selection occurring in the commensal niche
in the wider human population and that bacteremia represents a
spill-over from this population. This emphasizes the importance
of surveillance of the wider human population to understand
the dynamics and structure of invasive E. coli.
Methods
Bacterial isolates
A total of 1522 E. coli isolates were initially included in the study.
Of these, 1098 were from the BSAC Bacteraemia Resistance
Surveillance Programme (www.bsacsurv.org) (Reynolds et al.
2008) between 2001 and 2011 (Supplemental Table S2). Up to 10
isolates (when available) were obtained for each year from 11 con-
tributing laboratories distributed across England. The 11 centers
were selected in order to provide geographical and temporal diver-
sity. A further 424 isolates were sourced from the diagnostic labo-
ratory at theCUH.Using the laboratory database, we selected every
third isolate associatedwith bacteremia that had been stored in the
−80°C freezer archive between 2006 and 2012. Thirteen isolates
were subsequently excluded (four CUH isolates and nine BSAC
isolates) based on the low quality of sequence data or species
misidentification, giving a final sample size of 1509 isolates.
Antimicrobial susceptibility testing was performed using the
Vitek2 instrument with the N206 card (bioMerieux) for isolates
from the CUH and using the agar dilution method for the BSAC
collection (Andrews 2001). For the purposes of this analysis,
we combined phenotypic antibiotic-resistance data from BSAC
and CUH and grouped together the intermediate and resistant iso-
lates in the analyses to represent the nonsusceptible part of the
population. Since the isolates from the BSAC and CUH have
been tested against different antibiotic combinations, we have
antibiotic resistance data from 2001–2011 for amoxicillin and
imipenem; from 2006–2012 for amikacin, tobramycin, ampicillin,
ertapenem, meropenem, aztreoman, cefalotin, cefoxitin, cefe-
pime, and trimethoprim; and throughout the study period
(2001–2012) for gentamicin, tigecycline, cefuroxime, ceftazidime,
cefotaxime, ciprofloxacin, amoxicillin-clavulanic acid, and pipera-
cillin-tazobactam.
The National Research Ethics Service (ref. 12/EE/0439) and
the CUHResearch andDevelopment (R&D)Department approved
the study protocol.
DNA extraction and sequencing
Genomic DNA was extracted using a QIAxtractor (Qiagen), and
library preparationwas performed according to the Illumina proto-
col. Index-tagged libraries were created, and 96 isolates multi-
plexed per lane and sequenced using the Illumina HiSeq 2000
platform (Illumina) to generate 100-bp paired-end reads. The aver-
age sequencing depth was 77-fold, with a minimum of 48-fold.
Sequence data analysis
MLST was performed using an in-house script (Page et al. 2016b;
https://github.com/sanger-pathogens/mlst_check) and STs de-
fined using the Warwick MLST scheme (Wirth et al. 2006). De
novo assembly was performed using Velvet (Zerbino and Birney
2008), and scaffolds were generated using SSPACE (Boetzer et al.
2011) and GapFiller (Boetzer and Pirovano 2012). Reads were
mapped back to the assemblies using SMALT 0.7.5 (http://www.
sanger.ac.uk/science/tools/smalt-0). Assemblies were annotated
with an in-house pipeline based on Prokka (Seemann 2014).
Annotated assemblies were used in a pan-genome analysis in
Roary, from which a core genome alignment was generated (Page
et al. 2015). Lists of genes in the core genome and the core genome
alignment are presented in Supplemental Data S2 and S3, respec-
tively. A fasta file of representative gene sequences of genes in
the pan-genome is shown in Supplemental Data S4. These files
are also available from figshare (see “Data access”).
Bayesian analysis of population structure (hierBAPS)
(Corander et al. 2008; Cheng et al. 2013) was used to analyze the
population structure. A core genome alignment was produced
with Roary, and a SNP alignment was generated using SNP sites
(Page et al. 2016a) and used in hierBAPS, which was run five times
with the prior upper bound for the number of clusters varying be-
tween 100 and 300. All runs converged to the same estimate of the
global posteriormode partition, indicating a strong support for the
obtained clustering solution. Phylogenetic treeswere generated us-
ing SNP sites determined by SNP sites from the core genome align-
ments or from SNPs identified by mapping to reference genomes,
using RAxML 7.8.6 with 100 bootstraps (Stamatakis 2006). For the
reference-based SNP tree, the sequences were mapped against a
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selected reference genome using SMALT 0.7.5 (http://www.sanger.
ac.uk/science/tools/smalt-0), and SNPswere called using SAMtools
(Li et al. 2009). Reference genomes used in the analyses were
CFT073 (AE014075.1) and EC958 (NZ_HG941718.1) (Forde et al.
2014) for ST73 and ST131, respectively. Phage sequences were rec-
ognized using PHAST (Zhou et al. 2011) andweremasked from the
analysis. PHAST results can be retrieved from the program website
(phast.wishartlab.com). Gubbins with default settings was used to
identify recombination (Croucher et al. 2015), and the regions de-
tected were masked from the alignment. The resulting alignment
was used to produce a phylogenetic tree with RAxML.
Temporal analysis of ST69 and ST131 was performed with
BEAST 1.7.5.1-1 (Drummond and Rambaut 2007; Drummond
et al. 2012) on a reference-based alignment of 50 randomly select-
ed isolates from both STs. This approach was used since BEAST
did not converge with the complete collections or 100 isolates in
the available running time on the computer cluster. References
in the analysis were UMN026 (NC_011751.1) and EC958
(NZ_HG941718.1) for ST69 and ST131, respectively. PHAST was
used to identify phage regions and Gubbins was used to identify
regions of recombination in the alignment, and these regions
were masked from the alignment before running BEAST. The nu-
cleotide substitution model used was GTRGAMMA, and we ran
three replicates of all combinations for strict clock and lognormal
relaxed clock and three tree priors, coalescent: constant popula-
tion, exponential growth, and Bayesian skyline. To estimate
what was the best fitting model for each ST, we compared Bayes
factors from marginal likelihood estimations calculated by path
and stepping-stone sampling (Baele et al. 2012, 2013). Only the
models that converged well and had an effective sample size
(ESS) over 200 for each parameter were included in the test. The
best fitting model was used in the subsequent analyses. For
ST131, this was the Bayesian skyline model under the log-normal
relaxed clock, and for ST69, it was the constant population model
under the strict clock followed by the Bayesian skyline model un-
der the strict clock. For the construction of the Bayesian skyline for
ST69, we used data generated with the Bayesian skyline model un-
der the strict clock. The temporal analysis for ST131was confirmed
with LSD (version 0.3 beta) using all isolates (To et al. 2016).
In silico PCR was used to assign isolates to E. coli phylogroups
A, B1, B2, D, E, and F using the Clermont method (Clermont et al.
2000, 2013) to assign ST131 isolates to the B, H30-R (C1), andH30-
Rx (C2) clades (Price et al. 2013; Ben Zakour et al. 2016) and to per-
form plasmid incompatibility group/replicon typing (Carattoli
et al. 2005). Primers designed to detect clade-specific SNPs reported
by Ben Zakour et al. (2016) are presented in Supplemental Table S3.
In silico serotyping was performedwith SRST2 according to the in-
vestigator’s instructions with the database provided (Ingle et al.
2015). Here, serotype is defined by presence of known genes en-
coding serotype-determining enzymes. The results required minor
manual curating when the gene typing resulted in a discrepancy
between the gene pairs defining the serotype. This occurredmostly
with the novel sequences the investigators had included in the da-
tabase based on their own results. Antibiotic-resistance genes were
detected using SRST2 with 98% identity. An in-house curated da-
tabase based on ResFinder of antibiotic-resistance genes was used
as reference (Zankari et al. 2012). Parsimony reconstruction of
the presence of blaCTX-M-15 in ST131 was performed with the
Fitch algorithm (Fitch 1971). Virulence genes were analyzed
with SRST2 using the database and protocols described by the
investigators and using an Escherichia-genus-specific database
clustering together genes with 90% similarity and detecting
genes with 90% identity and at least 90% coverage (Inouye et al.
2014). Gene typing for gyrA, parC, and fimHwasperformedby clus-
tering sequences acquired from Roary using USEARCH (Edgar
2010). Clustering was based on reference sequences for seven
fimH genes, seven gyrA genes, and 10 parC genes. The alleles tested
were as described previously (Johnson et al. 2013) with the follow-
ing exceptions: fimH15 was omitted and fimH31 was added to the
analysis (Johnson et al. 2013).
Statistical testing
To test if a specific gene ismore often found in certain STs, we used
Pearson’s χ2 test statistic using prop.test in R (R Core Team 2015).
Data access
Sequence reads from this study have been submitted to the
European Nucleotide Archive (ENA; www.ebi.ac.uk/ena) under
the accession numbers listed in Supplemental Data S1. The lists
of genes present in the core genome and core genome alignment
and representative sequences for the core genes are available in
the Supplemental Data S2 through S4 and can be downloaded
from figshare (https://figshare.com/s/20dfe5842f952497619b
and https://figshare.com/s/3a12b011ff3c291a271b).
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